Tower Research Capital LLC (Trc) Dermata Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.18 - $184.8 $15 - $15,523	-84 Reduced 1.76%	4,688 $2,000
Q3 2022 Nov 10, 2022	SELL	$0.1 - $196.8 $2 - $4,329	-22 Reduced 0.46%	4,772 $2,000
Q2 2022 Aug 15, 2022	BUY	$115.2 - $319.2 $294,336 - $815,556	2,555 Added 114.11%	4,794 $3,000
Q1 2022 May 12, 2022	BUY	$223.2 - $571.2 $70,084 - $179,356	314 Added 16.31%	2,239 $3,000
Q4 2021 Feb 14, 2022	SELL	$374.4 - $1500.0 $992,534 - $3.98 Million	-2,651 Reduced 57.93%	1,925 $3,000
Q3 2021 Nov 15, 2021	BUY	$1000.8 - $1392.0 $4.58 Million - $6.37 Million	4,576 New	4,576 $21,000

Ticker DRMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,102,200
Market Cap $15.8M
Description
Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.